The Changing Landscape of Clinical Trials in Cancer Care - Oncology Nursing News
Genomic advancements have led to precision oncology, focusing on targeted therapies based on genetic mutations. Traditional phase 1-3 trials are evolving to target biomarkers regardless of tumor type. New master protocols, including basket, umbrella, and platform trials, aim to improve efficiency and uniformity. Oncology nurses must stay informed to counsel patients effectively.
Related News
Genomic advancements have led to precision oncology, focusing on targeted therapies based on genetic mutations. Traditional phase 1-3 trials are evolving to target biomarkers regardless of tumor type. New master protocols, including basket, umbrella, and platform trials, aim to improve efficiency and uniformity. Oncology nurses must stay informed to counsel patients effectively.